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Abstract
Mycobacterium tuberculosis is responsible for nearly 2 million deaths yearly. Upon
inhalation, mycobacteria are engulfed by alveolar macrophages. These cells produce
reactive oxygen and nitrogen intermediates (ROI’s and RNI’s), which normally kill
pathogens, but are ineffective against invading mycobacteria. What ensues, is the
formation of a tubercle to sequester the infected macrophages, and the initiation of a
latent tuberculosis infection, in which the mycobacteria enter a state of non-replicative
persistence (NRP). Glutathione (GSH), a host tripeptide thiol-based detoxification
molecule, protects host cells from ROI/RNI toxicity. Recently, it has been demonstrated
that GSH is toxic to in vitro and early infection mycobacteria, but no studies determined
whether GSH is toxic to latent mycobacteria. To further elucidate the impact of GSH on
mycobacteria, we exposed mid-logarithmic (mid-log) and NRP-induced M. bovis-BCG to
glutathione in its reduced (GSH), oxidized (GSSG), and nitric oxide associated (GSNO)
forms, for five days. We have demonstrated that the growth of mid-log M. bovis-BCG
(BCG) is inhibited by 4 mM GSH, and killed by 8 mM GSH. The growth of NRP
mycobacteria exposed to 4 mM GSH was inhibited similar to that of unexposed NRP
mycobacteria. In contrast, the growth of NRP BCG is stimulated four fold following
exposure to 8 mM GSH. We conclude that exposure of NRP BCG to 8 mM GSH
stimulates exit from the NRP state into an actively metabolizing state. 4 and 8 mM GSSG
and GSNO inhibited the growth of mid-log BCG; however, NRP BCG exposed to GSSG
and GSNO inhibited growth similar to that of unexposed NRP BCG. These results were
confirmed by performing viability studies, and analysis of free-intracellular cytoplasmic
ATP concentrations. Initially hypothesized, the toxicity to GSH was due to redox
potential imbalances within mycobacterial cytoplasm. Mycobacteria contain MSH
detoxification system (5), to cope with GSH. However, the mechanism of interaction
between the activation of the system and growth inhibition in mycobacteria is poorly
understood. HPLC analyses on mid-log and NRP BCG cytoplasms exposed to 4 and 8
mM GSH demonstrated that the activation of the detoxification system and the oxidative
stress of the mid-log and NRP cytoplasms were similar. This suggests that the activation
of the detoxification system and the oxidative state of the mycobacterial cytoplasm may
not play a direct role in mycobacterial growth inhibition and/or exit from the NRP state.

Introduction
Currently, one third of the world’s population is infected by Mycobacterium tuberculosis,
the causative agent of tuberculosis. The organism is responsible for nearly 2 million
deaths per year. Although these ratios are not predominant in the United States,
underdeveloped countries primarily contribute the increase in the number of deaths per
year. This is attributed to the lack of antibiotics accessibility to antibiotics, as well as the
rise of antibiotic resistant strains. In relation to the infection, a small percent of the
infected population is able to clear the infection and be asymptomatic. Majority of
patients infected with tuberculosis are either in active or latent infection.
Innate Immune Response
Upon inhalation of M. tuberculosis aerosols from an infected individual, the primary site
of infection resides within the inner lining of the lungs. Present resident alveolar
macrophages engulf the bacilli and isolate them within the phagosome. Within the
phagosome, reactive nitrogen intermediate (RNI) and reactive oxygen intermediates
(ROI) are introduced to the bacteria, creating a toxic environment aimed to kill the
pathogen (2). These intermediates are used to perturb the oxidative balance of the
invading microorganism, leading to cell death. Additional defense abilities of the
macrophage include acidification of the phagosome, and phagosome fusion with the
lysosome (37). These acidification processes, are aimed to destroy internal structures and
proteins of the bacteria, leading to cell death. M. tuberculosis is able to evade this innate
immune response by initiating factors that inhibit acidification by preventing
phagolysosomal fusion (1). In addition, they are able to overcome the oxidative stress
introduced by the host by using catalase/peroxidase enzyme (KatG) (23), superoxide
dismutase (43), and a thiol-based detoxification system (36). Collectively, these factors
assist the bacteria to evade multiple components of the host immune response, allowing
them to persist, and replicate within the macrophage.
Bacilli that are able to elude the adverse oxidative effects and phagosomal acidification
processes continue to multiply logarithmically for approximately two weeks after initial
infection inside the macrophage. At this point macrophages release chemokines and
interferon-γ (IFNγ) to actuate T-cell immunity and antigen-specific T lymphocytes,
which further activate the macrophages to kill the bacteria. However, this specific cell
mediated immune response is unable to eliminate the pathogen from the host, leading to
the formation of a granulomatous region called a tubercle; initiating latent infection (37).
Chemokines and cytokines are produced by infiltrating leukocytes and local tissue to
maintain the formation of the tubercle (35). The infiltration of these intermediates, at
increased concentrations, creates a central region of necrotic tissue within the granuloma;
the mycobacteria in turn use this necrotic tissue for nutrients (35). In the core of the
granuloma, the reactive nitrogen, oxygen, and other toxic immune components create an
hypoxic environment which leads to the formation of necrotic tissue. The coupling of
these two mechanisms limits the metabolic capabilities of the bacteria, in addition to
limiting the amount of available nutrients for the bacteria, over time. As a result, there are
changes in gene expression that force the bacteria into latent Tb infection (LTBI) (30).

Studies performed my Wayne et al. (2001) show that the transition to latent infection
occurs in successive stages, which are O2 dependent. The gradual depletion of oxygen
leads to nonreplicative persistence (NRP) state that is characterized by bacteriostasis,
metabolic, chromosomal, and structural changes in quiescent bacteria. In addition, the
NRP state is characterized by a shift from rapid to slow growth, significantly reduced
metabolic activity, followed by a complete shutdown of cell cycle progression (12). An
adaptive process associated with the NRP state in M. tuberculosis is the Dos-response
(DosR). Activation of this response allows the bacteria to enter the NRP state in order to
withstand extended alternative growth conditions, such as those present in the host (12).
DosT/S/R
In order to stimulate the latent NRP state in vivo in murine models, the bacteria require
the factors interferon- γ, tumor necrosis factor, or nitric oxide (4). When initiating latency
in vitro, the dormant state can be established by nutrient deprivation (4) and oxygen
depletion (40). In addition, low, non-toxic concentrations of NO are able to induce
dormancy in mycobacteria (38). Specifically, the NO competes with O2 to bind to DosR,
inducing 48 latency genes. The DosR regulon is expressed when exposed to nontoxic
concentrations of NO and CO, and the induction of the regulon is inhibited in the
presence of oxygen (3, 19, 20, 28, 29, 31, 32, 34, 38, 42). Two important signal
regulators DosT and DosS autophosphorylate, then transfer a phosphate to the DosR
regulon, activating DosR (27). Both the DosT and DosS sensors are bound to heme
groups that bind to the activating or deactivating divalent gasses: NO, CO, and O2. The
interactions of the divalents with the heme group are responsible for ultimately activating
and deactivating DosR (6, 19, 28, 29, 33). DosT is identified to be the hypoxia sensor;
when oxygen is bound to DosT the activation of DosR is inhibited. When the heme group
present on the DosS receptor is oxidized in the presence of high oxygen concentrations,
DosR sensor is rendered inactive. DosS however is the redox sensor, once the heme
group on the sensor is reduced to Fe2+ from Fe3+, signaling for DosR activation occurs (6,
19). It is possible for NO and CO to displace O2 from the DosS and DosT heme groups,
resulting in activation of DosR (6, 21). Due to the high binding affinities of NO and CO
to the iron present in the heme group, they are capable of locking the DosR sensor in the
active state. Overall, the induction and maintenance of NRP due to DosR activation is
dependent on the presence and concentration of CO and NO
Glutathione
Simultaneous to the production of ROIs and RNIs, the cells of the immune response
produce glutathione (GSH), a component of the host thiol-based detoxification system.
GSH is a tripeptide comprised of γ-glutamate, cysteine, and glycine, which functions as
an antioxidant found in all cells of the body, including macrophages (9). Glutathione
protects phagocytic host cells from oxidative toxicity associated with the release of ROIs
and RNIs, chemokines, and cytokines, by maintaining a reduced environment within the
host cytoplasms (36). The intracellular host concentration of GSH is approximately 1-8
mM, and is 1000 fold higher than the plasma concentration, which is approximately 5-50
µM (11, 16). During oxidative stress, GSH is oxidized to glutathione thiodisulphide
(GSSG); GSSG is converted back to GSH by GSH reductase; a NADPH-cofactor
requiring conversion (11, 16). In contrast to GSH, GSSG acts to maintain a reduced

environment for in organellic structures within the host macrophage. In addition, GSH
can react with NO to form S-nitrosoglutathione (GSNO); the stability of NO is increased
once bound with GSH (9). During initial infection, GSNO serves as an NO donor to
interfere with the pathogenesis of invading microorganisms including mycobacteria (10,
25). GSNO has been shown to be responsible for killing M. tuberculosis in mice (15).
GSH can be transported into the bacterial cell as a tripeptide, dipeptide, or single amino
acids using ABC oligopeptide transporters (Opp) (7). Exoenzymes secreted by Mtb are
able to break down GSH into it a dipeptide, and into its individual amino acids. The
action of the exoenzyme γ-glutamyl transpeptidase (GgtA), GSH is cleaved into cys-gly
and γ-glutamate (10, 22). Cys-Gly is transported into the cell by an ABC transporter
dipeptide permease (Dpp) (9). Although in-depth analyses have been performed, the
mechanism of GSH toxicity in mycobacteria is still unknown. A prevalent theory
suggests that an imbalance is created in the mycobacterial thiol detoxification system
(mycothiol), leading to an oxidation/reduction imbalance, resulting in cell death (26).
This imbalance is created due to the import of cys-gly into the mycobacteria cell (9).
Bacterial Mycothiol (MSH)
Bacterial mycothiol (MSH) is the major low-molecular-mass thiol present in
mycobacteria. MSH is found only in actinomycetes, and at high concentrations in
Mycobacterium tuberculosis. The functionality of mycothiol is analogous to that of
mammalian thiol based detoxification system – glutathione. It is known that glutathione
is not present in Mtb. Therefore, similar to glutathione; mycothiol acts to maintain the
oxidative state of the mycobacterial cell; by interconverting between MSH and MSSM.
Mycothiol activity protects M. tuberculosis from toxic oxidants produced by antibiotics
and the macrophage itself, such as ROIs and RNIs (5). An alteration in mycothiol activity
is shown to alter the overall oxidation state of the bacterial cell. Specifically, an altered
oxidation state can influence the cell wall components altering the cell wall permeability,
leading to greater molecule exchange between extracellular and intracellular components
and bacterial cell death (5). By evaluating the oxidative balance of mycothiol upon
exposure to toxic concentrations of glutathione will help elucidate the function of
glutathione.
Primary Focus
It has recently been demonstrated that both GSH and GSNO are toxic to mycobacteria
both in vitro and in vivo early infection models (prior to the formation of the tubercle)
(9). GSNO toxicity is likely due to the mycobactericidal effects of NO release from
GSNO (7). It has been hypothesized that the toxicity to GSH results from a redox
potential imbalance in the mycobacterial cytoplasm leading to growth inhibition. In vitro
studies have demonstrated that M. tuberculosis uses MSH to cope with both GSH and
GSNO (2) but, the underlying mechanisms surrounding the balance between the
activation of this system and mycobacterial killing in vitro and in vivo early infection
models is poorly understood. In addition, there have been no studies to determine if GSH
and GSNO are toxic to mycobacteria residing within the tubercle during latent infection.
In order to further confirm previous studies and continue investigation of M. tuberculosis
in the NRP state, both mid-logarithmic and NRP cells were treated with GSH, GSSG, and

GSNO, over five days, at concentrations of 4 mM and 8 mM concentrations; these
concentrations mimic GSH levels present within the alveolar macrophage. We performed
growth studies supplemented with the cell viability assays, and intracellular free ATP
concentration assays to determine the bacteriostatic and bactericidal effects of each
glutathione derivative at the varying concentrations. HPLC analysis was performed to
investigate the impact of glutathione on the oxidative state of the mycobacterial
cytoplasm.
We confirmed that 4 mM GSH is bacteriostatic, and 8 mM GSH is bactericidal to midlog M. bovis-BCG over five days. In addition, our results showed that 4 mM and 8 mM
GSSG and GSNO were bacteriostatic to mid-log M. bovis-BCG over the five-day period.
NRP BCG exposed to 4 mM GSH, and 4 mM and 8 mM GSSG and GSNO showed no
significant impact on the growth of NRP BCG. Surprisingly, 8 mM GSH with NRP BCG
showed an increase in growth, suggesting exit from the NRP state. HPLC analysis
confirms that stimulated growth is not due to an imbalance in the oxidative state of the
mycobacterial cytoplasm. Our new hypothesis suggests that the transition from NRP to
mid-log is due to cellular signaling, resulting in a deactivation of the DosR system due to
the binding of oxygen to the DosT receptor.

Material and Methods
Bacterial Strains and Growth
M. bovis-BCG Pasteur strain was grown in Middlebrook medium. Middlebrook 7H9 (liquid) and
7H11 (1.5% agar) media (Sigma) were supplemented with glycerol (0.5%, vol/vol) and ADC
supplement (0.5% albumin – from bovine serum [Sigma], 0.2% dextrose, 0.85% NaCl). All
liquid cultures of BCG were supplemented with 0.05% Tween 80 (Sigma). All cultures were
incubated in a rotating incubator at 37°C
Mid-log BCG cells were inoculated in in 7H9 supplemented with glycerol (0.5%, vol/vol) and
ADC supplement (0.5% albumin – from bovine serum [Sigma], 0.2% dextrose, 0.85% NaCl).
The non-replicating persistence (NRP) oxygen depletion model developed by Hu and colleagues
(2003) was replicated to induce NRP BCG (in vitro) cells at 37°C. NRP cells remained
stationary for 100 days, without agitation, in a low oxygen environment.
M. bovis – BCG Growth Curve
Five-day growth cultures were inoculated on day 1 with mid-logarithmic BCG or NRP BCG at
OD600 of 0.1, in 7H9 media with ampicillin (1 mg/mL) in 15 mL sterile conical tubes. 1 mL
aliquots were removed daily to assess cell density at OD600 over five days. All mid-log BCG
cultures were incubated in a shaking incubator. All liquid NRP trail cultures were placed in a
stand still incubator. Sterile glass beads were added to each NRP trail tube to compensate for the
volume displacement to ensure an anoxic environment. All samples were incubated at 37°C.
Trails consisted of samples at 0 mM, 4 mM, and 8 mM concentrations of GSH, GSSG, and
GSNO. 4 mM and 8 mM GSH and GSSG were added daily for four days. Samples treated with
GSNO were inoculated at concentrations of 4 mM, and 8 mM only once, on the initial day. Each
trail was performed in triplicate.
M. bovis –BCG Inhibition/Killing Viability Assay
A 10 µL aliquot of each sample was removed while performing the growth curve studies, and
were diluted by a (1/100,000 serial dilution), and 100 µL were plated on 7H11 agar. Plates were
incubated at 37°C for 27 days. CFU were quantitated and normalized according to the dilution
factor.
M. bovis –BCG Cell Intracellular ATP Quantization
Quantitation of intracellular ATP was performed according to the BacTiter-GloTM Microbial Cell
Viability Assay [Promega]. Samples were removed daily and diluted to OD600 of 0.1. The
chemiluminescence of the ATP reaction was determined using a Gel Logic 2200 PRO
luminometer.
Cell Extraction for Thiols Analysis
Cell aliquots were taken in triplicates from the growth trails and normalized to OD600 of 0.1.
Extracts were labeled with monobromobimine (mBBr) for thiol analysis as described in Newton
et al. (1996). Modifications were made in which cell extracts were micro-centrifuged at 3,000xg,
10 min, 4 0C; aspiration of the media was performed, and cells were resuspended in 0.500 mL
inactivation buffer [20 mM HEPES buffer (pH 8.0), 50% ACN, and 2 mM mBBr]. Cells were

placed at 60 0C for 15 min, and were micro-centrifuged at 21,100xg for 20 min; to pellet cellular
debris. Supernatants was aspirated, and stored at -80 0C.
HPLC Analyses of Thiol-mB Derivatives
The thiol bimine derivatives (RSmB) were analyzed using a modified HPLC method 1 (13, 24)
to provide improved separation of the compounds. A LC 410 pump (Perkin-Elmer, Norwalk,
CT) coupled to a C-18 10um column (4.5mm x 250mm) at a flow rate of 1 ml min-1 was used
with buffers A (0.25% acetic acid in H2O titrated to pH 3.6 with NaOH) and buffer B (HPLC
grade methanol, Fisher). The linear gradient was as follows: 0 min, 10% B; 10 min, 10% B; 25
min, 18% B; 40 min, 27% B; 50 min, 50% B; 60 min, 100% B; 65 min, 10% B; 75 min, 10% B
reinject. The retention times are as follows: 2:16 min, γ-glu-cys; 12:12 min, L-cys; 10:48 min,
cys-gly; 12:12 min, GSH; 18:32 min, MSH. NRP Samples were diluted 1:1 using
methanesulfonic acid prior to injection.

Results
M. bovis – BCG GSH Growth Curve
In order to investigate the effect of glutathione on the growth of BCG, we performed triplicate
growth trials over five days by exposing BCG to 4 and 8 mM GSH. On Day 1, unexposed, 4
mM, and 8 mM mid- log and NRP samples were all normalized to an OD600 of 0.1 (Figure 1a).
Spectrophotometer analyses of bacterial growth over five days upon exposure to GSH shows that
mid-logarithmic unexposed BCG exponentially grew to reach a maximum OD600 of 0.797 on
Day 4. Mid-logarithmic BCG exposed to 8 mM GSH show decreased levels in bacterial growth –
reaching a maximum OD600 of 0.240. Mid-logarithmic BCG exposed to 4 mM GSH over five
days resulted in similar optical densities to that of unexposed BCG; having a maximum OD600 of
0.694. These growth studies propose that GSH is toxic to mid-log BCG over five days. However,
they do not confirm if the cells are being inhibited or killed.
Optical density analyses performed on NRP BCG (Figure 1b) resulted in no significant increase
in growth of unexposed NRP bacteria. The maximum OD600 reached was 0.131. Similar results
are shown for NRP BCG exposed to 4 mM GSH over a five-day period. The maximum OD600
was 0.135. NRP BCG exposed for 8 mM GSH over five days, resulted in a significant increase in
optical density. On Days 1, 2, and 3 the highest OD600 of 8 mM NRP BCG was 0.125.
Remarkably, on Day 4 the OD600 increased to 0.207, and on Day 5 the OD600 of 8 mM NRP BCG
was 0.398. These results suggest that 8 mM GSH facilitates in the exit from the NRP state to
mid-logarithmic growth.
M. bovis –BCG GSH Inhibition/Killing Viability Assay
Based off the results obtained from the growth studies, in order to determine whether GSH
inhibited or killed mid-log and NRP BCG, we performed cell viability assays. On Day 1,
unexposed, 4 mM, and 8 mM mid- log and NRP samples were all normalized to a bacterial count
of 1.0 x 108 bacterial cells per mL. The mid-log (Figure 2a) unexposed results show that there is
an average of 2.5 x 109 total viable cells over five days. Mid-log BCG exposed to 4 mM GSH,
show there are viable bacterial cells, with a total average cell count of 2.2 x 109 over the five-day
period. In contrast, mid-log BCG exposed to 8 mM GSH exhibited no colony forming units on
Day 4 and 5. Viable CFU were quantitated between Day 1 and 3 for mid-log 8 mM GSH
exposed BCG. On Day 3, mid-log BCG exposed to 8 mM GSH presented an average cell count
of 3.0 x 109; similar to that of 0 and 4 mM GSH exposed mid-log BCG. The cell viability of 8
mM GSH exposed mid-log BCG was conducted to investigate the number of viable cells in
relation to the growth curve pattern. These killing results show to be consistent with the growth
curve pattern. They confirm that the bacterial cells are indeed being killed over five days.
NRP BCG (Figure 2b) exposed to 4 and 8 mM GSH did not show statistically significant
deviations in cell count on days 1, 2, 3, and 4. Viability analysis of NRP BCG on Day 5 shows
an increase in the number of bacterial cells for unexposed, 4 mM GSH, and 8 mM GSH.
Normalization of the data presented in Figure 2c to an OD600 of 0.1 shows on Day 5 there are less
viable bacterial cells upon exposure to 8 mM GSH. On Day 5 of the NRP BCG viability trials,
there were 3.53 x 108 viable unexposed BCG cells; 3.34 x 108 viable 4 mM exposed BCG cells,
and 9.59 x 107 viable 8 mM exposed BCG cells. The lower viability noted after normalization

indicates that BCG is exiting the NRP state to mid-log growth. During this transition, GSH then
kills the BCG, as seen in the mid-log growth trials.
M. bovis – BCG GSH Exposed Intracellular ATP Quantization
The ATP assays were performed to determine the free ATP present in mid-log cells in
comparison to NRP to confirm that the NRP state maintains a low metabolic profile, consistent
with low metabolic energetic needs. Also, by evaluating the free intracellular ATP
concentrations present within the cells over the five days upon exposure to GSH, we were able to
confirm the killing of mid-log and NRP BCG. In addition, evaluating the energetics of the cell
helped elucidate the cellular response upon exposure to glutathione. Normalization of mid-log
BCG cells (Figure 3a) on Day 1 resulted in an intracellular ATP concentration of 0.108 uM
(unexposed BCG), 0.117 uM (4 mM GSH exposed), and 0.130 uM – (8 mM GSH exposed). On
Day 5, unexposed mid-log BCG intracellular ATP concentration reached a maximum of 1.380
uM. However, over the 5 day period, the ATP concentration was between 0.108 – 1.380 uM. The
ATP concentration within 8 mM GSH exposed mid-log BCG was between 0.130 – 2.284 uM.
On Day 3, the ATP concentration of 8 mM GSH mid-log BCG was 1.596 uM; on Day 4 the
concentration increased to 2.284 uM, and on Day 5, the 8 mM GSH mid-log ATP concentration
decreased to 0.779 uM. These results suggest that through Day 3 there is an increase in ATP in
samples treated with 8 mM GSH, in attempts to overcome the toxicity of glutathione. On days 4
and 5 a decrease in free intracellular ATP is noted due to cell death; confirmed by the cell
viability assay. This 17.5 fold increase in intracellular free ATP can be explained through two
perspectives. The first relies on the basis of activation of the bacterial SOS response, in which
the cell increases its metabolic needs, DNA repair mechanisms, increased protein output, and
increased cellular respiration in order to overcome the external stress.
For NRP BCG the assay helped determine whether the energetic needs of the cell were increased
or decreased to facilitate the exit from the NRP state. Intracellular ATP concentration in NRP
BCG (Figure 3b) was minimal in 8 mM GSH in days 1-5, while unexposed BCG showed
increased concentrations on day 3, 4, and 5. The initial Day 1 ATP concentration for unexposed
NRP BCG was 0.017 uM. The following days showed increased levels between 0.746 – 1.698
uM between days three and five. NRP BCG exposed to 8 mM GSH showed on Day 1, 2, 3, and 4
to have intracellular ATP concentrations between 0.016 – 0.045 uM. On Day 3, an increase in
intracellular ATP is noted at 0.197 uM; the maximum over the five day trial. The lack of increase
in ATP over the five days is suggestive that an upregulation in ATP production is not seen
because the ATP is being utilized to exit the NRP state.
M. bovis – BCG GSH Exposed HPLC Thiol Analysis
In order to further investigate the role of GSH with respect to the oxidative state of the
mycobacterial cytoplasm, we performed thiol HPLC analysis on mid-log and NRP BCG over
five days. This analysis was used to compare the intracellular levels of GSH, MSH, Cys-Gly, Lcys, and γ-glutamate. Alterations in these various compounds will elucidate oxidative changes
that occur due to the direct or indirect interaction of GSH in NRP BCG. Figures 4 a, b, and c,
show the separation of exposed NRP BCG intracellular compounds based on the Thiol analysis
as described above. This separation was performed using 0.25% Acetic Acid (pH 4.2) for
increased separation between cys-gly/L-cys (12;36 min), mixture of GSH, and/or dipeptide cysGly and/or L-cys (14:55 min) and MSH (18:52 min). Due to the relative similarities of GSH,

cys-gly, and L-cys, complete separation of the peaks for cys-gly, L-cys, and GSH is not shown.
These results show an increase in base area for cys-gly and L-cys in samples exposed to 8 mM
GSH (Figure 4a/c). There is an increase in either GSH/cys-gly/L-cys, which over five days gives
raise to the mixture-defined region. This base widening is noted on Day 5 in all triplicate
samples of 8 mM GSH NRP BCG. In comparison to unexposed NRP BCG samples (Figure
4a/b), there is no significant expansion of the mixture-defined region over five days. Which
suggest that there is no import of GSH, cys-gly, or L-cys into the mycobacterial cell. With
respect to mycothiol (Figure 4d) the average base area correlating to the concentration of MSH
in 1 x 108 bacterial cells is not significantly different over the five days when comparing
unexposed and 8 mM GSH exposed cells. The average base area concentration seen between
days 1 and 3 is 11,000 – 13,000 units. On Day 4 however, a decrease in mycothiol concentration
is noted in 8 mM GSH exposed samples. In comparison to the data as a whole, there is no
significant difference in the mycothiol concentration data represented for both exposed and 8
mM GSH exposed NRP BCG. These results confirm that there is no significant change in the
oxidative balance of the mycobacterial cell. However, in NRP BCG exposed to 8 mM GSH, the
decrease in mycothiol on Day 4 may be attributed to the exit from the NRP state due to GSH and
oxygen.
M. bovis – BCG GSSG Growth Curve
Similar to the growth curve of GSH, in order to investigate the effect of oxidized glutathione on
the growth of BCG, we performed growth triplicate growth trials over five days by exposing
BCG to 4 and 8 mM GSSG. On Day 1, all culture presented were normalized to an OD600 of 0.1.
Mid-log BCG exposed to the oxidized glutathione, GSSG (Figure 5a), at concentrations of 4 and
8 mM shows results similar to that of mid-log BCG exposed to GSH. Unexposed BCG followed
the exponential mid-logarithmic growth patter, and over the five days increased to an OD600 of
0.773. Mid-log BCG exposed to 4 mM GSSG, showed limited growth between Days 2-5. An
OD600 of 0.258 – 0.314 was maintained over that four day period. 8 mM GSSG exposed mid-log
BCG showed an increase to OD600 of 0.238 on Day 2; and decreased to OD600 of 0.120 on Day 5.
These results suggest that GSSG is toxic to mid-log BCG, however these studies do not confirm
cell death or inhibition. To further confirm the toxicity of GSSG, plating assays were performed.
On Day 1, all NRP samples were normalized to an OD600 of 0.1. NRP BCG exposed to GSSG
(Figure 5b) showed no statistical deviations when exposed to 4 and 8 mM GSSG compared to
unexposed BCG over five days. Between Day 2-5, the cell density increased to an average OD600
of 0.249, for unexposed, 4 mM GSSG, and 8 mM GSSG. These growth results suggest that
GSSG has no effect on the growth of NRP BCG over five days; to validate these results, plating
assays were performed.
M. bovis –BCG GSSG Inhibition/Killing Viability Assay
After performing growth studies to evaluate the effects of GSSG on mid-log and NRP BCG, we
performed cell plating assays to determine whether GSSG inhibited or killed the BCG. The cell
viability assay for mid-log BCG exposed to GSSG (Figure 6a) shows an increase in the number
of viable unexposed bacterial cells present over the five days. Over the five-day trial period,
there was a maximum of 4.74 x 109 viable unexposed mid-log BCG cells present on Day 4. Midlog BCG treated with 4 mM GSSG showed in increase in viable cell count throughout the five
days, increasing to 5.44 x 109 cells on Day 5. In addition, mid-log BCG exposed to 8 mM GSSG

showed an increase in viable cell count over the five-day period. The maximum number of viable
cells is noted on Day 5 to 4.09 x 109 cells. Analysis of these results confirms that both 4 mM and
8 mM GSSG is capable of inhibiting mid-log BCG, but are unable to kill the bacteria.
NRP BCG cells treated with 4 mM and 8 mM GSSG (Figure 6b) showed a viable number of
cells over five days. In comparison to unexposed NRP BCG cells, which also showed a viable
number of cells over five days is comparable to that of GSSG treated cells. Over the five days,
all three trial types had an average of approximately 2 x 107 viable cells. No significant deviation
or change is noted in the number of quantifiable bacterial cells in each trial. These results
confirm that upon exposure to varying concentrations of GSSG, the growth and viability of NRP
BCG is not affected.
Mid-log and NRP BCG GSSG Exposed Intracellular ATP Quantization
After confirming the inhibition of mid-log BCG growth upon exposure to GSSG, we performed
intracellular ATP assays to determine the utilization and accumulation of ATP in the cells over
five days. Intracellular ATP analysis of mid-log BCG exposed to 4 and 8 mM GSSG (Figure 7a)
show to have similar trends in intracellular ATP concentrations over five days; consistent with
that of unexposed mid-log BCG. On Day 1, the average intracellular concentration of unexposed,
4 mM GSSG exposed, and 8 mM GSSG exposed was 0.091 uM. Unexposed mid-log BCG
presented an average intracellular ATP concentration of 1.308 uM on Day 4, and 1.149 uM on
Day 5. 4 mM GSSG exposed mid-log BCG presented increased intracellular ATP concentrations
on Day 2 (0.336 uM), Day 3 (1.029 uM), and Day 4 (1.773 uM). A decrease to 1.294 uM was
noted on Day 5 in comparison to Day 4. When mid-log BCG is treated with 8 mM GSSG, an
increase in intracellular ATP is presented through Day 4. Similar to that of 4 mM GSSG, a
significant decrease in intracellular ATP concentrations is noted. Between Day 1 and 4, the
intracellular ATP concentration increases from 0.091 uM to 2.097 uM; and on Day 5 the
intracellular concentration is reduced to 1.294 uM.
With respect to NRP BCG exposed to varying concentrations of GSSG, we performed the
intracellular ATP assay to determine that the NRP BCG cells are indeed viable, in addition to the
BCG remaining in the NRP state and utilizing the same amount of ATP as unexposed NRP
BCG. NRP BCG exposed to GSSG exhibit decreased intracellular ATP concentrations in
comparison to mid-log BCG exposed to GSSG (Figure 7b). Unexposed NRP BCG on Day 1
presented an intracellular ATP concentration of 0.017 uM. A significant increase is noted on Day
(0.476 uM), and Day 5 (0.697 uM), which is maintained into Day 5 (0.553 uM). NRP BCG
exposed to 4 mM GSSG shows to have an increase in ATP over four days; 0.024 uM - 0.886 uM.
On Day 5, a decrease is noted to 0.633 uM. In comparison to unexposed and 4 mM GSSG
treated, 8 mM GSSG treated cells exhibited the greater free intracellular ATP concentrations. On
Day 1, the concentration was 0.016 uM; a significant increase is occurs on Day 3 (0.683 uM),
and a maximum on Day 4 (1.079 uM). A decrease in intracellular ATP concentration is noted on
Day 5 (0.547 uM) by a factor of 1.97. Upon evaluation of cell energetics, all samples resulted in
similar free ATP values over the five-day period. Taken together, these results confirm that the
growth of NRP BCG is not affected by the exposure to GSSG.

M. bovis – BCG GSNO Results
In order to further investigate the effect of the final glutathione derivative, GSNO, we performed
growth studies, cell viability plating, and intracellular ATP assays to determine its effects on
mid-log and NRP BCG. Although not presented, mid-log and NRP BCG was exposed to 4 and 8
mM GSNO, over a five day period. These growth studies were evaluated similarly to that of
GSH and GSSG. The growth curve, cell viability assay, and intracellular ATP assay results did
not show statistically varying data when compared to that of GSSG. Figures 5, 6, and 7 can attest
to the data presented by the GSNO studies. In addition, HPLC thiol analysis upon exposure to
GSSG and GSNO has not been completed. The results from all three assays confirm that GSNO
is only capable of inhibiting mid-log BCG cell growth, and has no effect on the growth and
replication of NRP BCG.

Discussion
Influence of GSH on Mid-log and NRP BCG
Four distinct phases characterize the growth of bacteria over a period of time. These successive
stages define the growth curve, which consists of a lag, log, stationary, and decline phases. Our
results show that the mid-log BCG unexposed bacteria exhibit mid-logarithmic growth with
approximately an eight-fold increase in optical density over the five days. This was similar to
Mid-log BCG exposed to 4 mM GSH (Figure 1a). After evaluating the viability tests (Figure 2a)
to confirm the bacteriostatic effects of 4 mM GSH, we conclude that M. bovis-BCG is capable of
detoxifying 4 mM GSH, and is not detrimental to its growth. This is supported by the presence of
quantified viable CFU over the five-day period. In addition, when evaluating the energetics of
unexposed and 4 mM GSH exposed bacilli (Figure 3a), both cell trials followed similar patterns
of ATP utilization over the five days. This data suggests that M. bovis-BCG growth is not
inhibited by 4 mM GSH.
The growth of mid-log BCG was completely halted upon exposure to 8 mM GSH over five days
(Figure 1a). The viability data shows quantifiable colony forming units on days 1, 2, and 3.
However, in support of 8 mM GSH being toxic to BCG, there are no quantifiable colony forming
units on days 4 and 5. The intracellular free-ATP quantization assay (Figure 3a) shows that there
is a 17.5 fold increase in free intracellular ATP by Day 4. An up-regulation in genes and systems
controlling these aspects of the cell, require an influx of free ATP. Therefore, over the four-day
period, the cells are attempting the overcome the stress implemented by toxic levels of GSH. The
second perspective emphasizes that toxicity due to GSH has already killed the bacterial cells.
However, the cells have not lysed, resulting in an accumulation of ATP. The decrease in ATP
levels on Day 5 can be explained by the lack of bacterial growth and replication due to consistent
exposure to toxic concentrations of GSH. Although these three analyses collectively confirm that
8 mM GSH does kill mid-logarithmic, they fail to propose a definitive explanation as to how
GSH is able to kill the cells. Previous studies have assessed the interaction of GSH with mid-log
BCG have shown that Dpp and Opp transporters in the cell membrane of the bacteria uptake
glutathione, or uptake cy-gly. These two components can be attributed to the toxicity of
glutathione (8).
Nevertheless, no studies have been performed to determine the effects of GSH on NRP BCG.
We performed a growth study over five days to evaluate the effect of GSH on the growth of NRP
BCG. Our study revealed that unexposed NRP BCG remained in NRP and no conversion to midlogarithmic growth was observed. The maximum OD600 obtained and maintained was
approximately 0.135. Similarly, NRP BCG exposed to 4 mM GSH revealed no changes in
growth, or exit from the NRP state. The maximum OD600 of 4 mM GSH exposed NRP BCG was
0.135. (Figure 1b). The inhibition and viability assays performed for unexposed and 4 mM GSH
exposed NRP BCG show there are viable cells throughout the five days. In addition the viability
indicates that there is no increase in the number of viable cells; suggesting that cells in both of
these trials have remained in NRP. In relation to cell energetics, the initial concentration of free
ATP in unexposed NRP BCG was 0.071 uM, and 0.024 uM in 4 mM GSH NRP BCG.
Throughout the progression of the trail, unexposed NRP BCG did show increased levels of free
ATP on days 3, 4, and 5; ranging between 0.746 uM and 1.698 uM. 4 mM GSH NRP BCG
followed a similar increase in free intracellular ATP, but the concentrations ranged between

0.241 uM and 0.406 uM. This accumulation of ATP in the cell may be attributed to the
regulation of the NRP state, ensuring the cells remain in NRP. Also, when the cells are in the
NRP they have decreased metabolism, suggesting that this basal amount of ATP is necessary to
keep the cell alive in the low metabolic state. The ATP assay was performed to confirm that the
free ATP present in mid-log BCG is significantly greater than that in NRP BCG. Also, by
evaluating the free ATP in mid-log and NRP determined whether the induced NRP state was
maintained over the five days.
Our most significant findings reveal an unexpected growth of NRP BCG upon exposure to 8 mM
GSH over five days. On Days 1, 2, and 3 the optical density remains within a standard deviation
of 0.100. On Day 4, the optical density of the 8 mM GSH NRP BCG average increases to 0.207;
a two fold increase in cell density. Furthermore, on Day 5, the average optical density increased
to 0.398, also by a factor of two. This data presents an enigma as to how the bacteria are able to
exit the NRP state, and enter active mid-logarithmic growth. Cell viability assays performed on
NRP BCG revealed a ten fold lower number of cells in comparison mid-logarithmic bacterial
cells. This is consistent with the models developed to explain the relative abundance of bacterial
cells in active growth, and lack of active replication in latent mycobacteria (39). On Day 5, the
viability assay (Figure 2b) indicates an increase in the number of CFU for unexposed, 4 mM
GSH, and 8 mM GSH exposed NRP BCG. Upon normalization of the data for an OD600 of 0.100
(Figure 2c), the data shows there are viable cells in unexposed and 4 mM GSH NRP BCG. Thus,
unexposed and 4 mM GSH BCG does not exit the NRP state. In contrast, the normalization of 8
mM GSH NRP BCG shows an approximate two fold decrease in the number of viable NRP
mycobacteria. This data suggests that 8 mM GSH stimulates the transition from the NRP state to
active mid-logarithmic growth. Once the mycobacteria have entered mid-log growth, 8 mM GSH
acts to simultaneously kill the BCG. This killing is consistent with the killing data presented in
our mid-log trials. In order to substantiate this claim, the energetics of the NRP BCG were
evaluated over the five days. NRP mycobacteria exposed to 8 mM GSH showed to have basal
free ATP levels of 0.016 – 0.045 uM. An increase in free ATP to 0.197 uM is noted on Day 3.
Quantitatively, this is approximately a ten-fold increase in free ATP. On days 4 and 5, the
intracellular free ATP levels returned to the basal as reported on days 1 and 2. This data supports
the NRP exit because on Day 3, the increase in free intracellular ATP could potentially indicate
that the cells are increasing their metabolic needs, in addition to various other cellular regulatory
processes, to exit the NRP state. On days 4 and 5 the ATP levels return back to normal because
this ATP is being utilized. However, on Day 5, it is hypothesized that the cells are in midlogarithmic growth, and 8 mM GSH acts to kill the mycobacteria; thus explaining the decreased
free intracellular ATP levels.
Previously, it has been hypothesized that GSH acts to create an oxidative imbalance within the
mycobacterial cell, resulting in cell death (7). Currently, thiol HPLC analysis studies are being
performed to determine the overall mycobacterial oxidative state of mid-log BCG exposed to 8
mM GSH. The results from the NRP HPLC mycothiol analysis (Figure 4d), show on Day 4 a
decrease in mycothiol concentration in 8 mM GSH NRP BCG cells. This decrease in mycothiol
may be suggestive of a mechanism or response from exposure to GSH, leading to exit from the
NRP state. However, no studies have been performed to evaluate whether the changes in the
oxidative state of the NRP cytoplasm facilitate the exit from the NRP state.

In order to fully evaluate the exit from NRP, the DosR regulation mechanism must be taken into
account. Over the five days, the design of the protocol exposes the bacteria to a minimal, but
uncalculated low concentration of oxygen. In order to maintain a hypoxic environment, sterile
glass beads are added to reduce the headspace of free available oxygen in each culture tube,
consistently over five days. Other procedures use more advanced molecular techniques to ensure
that the mycobacteria remain in the NRP state by exposing them to low non-toxic concentrations
of CO or NO (38). These molecules occupy the binding site of the DosR system, initiating and
‘locking’ the transition into latency. Once bound, due to binding affinities, these molecules
cannot be displaced, even in the presence of environmental oxygen. When manipulating the
Wayne model for NRP, latency is achieved by extended non-shaking incubation, which
eventually creates an anoxic environment through activation of the DosR regulon. When no
oxygen molecules are eventually binding onto the DosR binding site, the latency genes are
successively upregulated – inducing NRP. The introduction of low concentrations of oxygen can
potentially allow binding to the DosR system at the heme group of DosT, reversing the process,
and promoting exit from the NRP state. We hypothesize that the introduction of low
concentrations of oxygen coupled with the activity of GSH (although unknown) induces exit
from the NRP state. Furthermore, these results suggest that GSH can act or mimic a direct or
indirect inducer for pathways associated with the regulation of the NRP state.
Influence of GSSG/GSNO on Mid-log and NRP BCG
The oxidized form of glutathione (GSSG) was also tested against mid-log and NRP BCG over
five days to assess the impact of the compound on both cell stages. Mid-log BCG exposed to 4
and 8 mM GSSG presented data similar to that of mid-log BCG exposed to GSH (Figure 5a).
The growth curve, cell viability assay, and intracellular ATP assay have collectively confirmed
that that GSSG inhibits cell growth, but is not able to kill the cells.
NRP BCG exposed to 4 and 8 mM GSSG revealed no deviation in the growth curve in
comparison to unexposed NRP BCG (Figure 5b). Over the five day trial period, the OD600
increased from 0.100 (Day 1) to 0.249 (Day 5) for all three sample types. The cell viability assay
results show there are similar cell units in each sample progressively over the five days (Figure
6b). These data are indicative of neither bacterial growth stimulation nor killing.
Growth studies, cell viability assays, and cell energetic assays were performed for mid-log and
NRP BCG exposed to 4 and 8 mM GSNO. However, due to similarity of results with mid-log
and NRP BCG exposed to GSSG, the data is not presented. Similar to that of mid-log BCG,
GSNO showed to inhibit the growth over five days; killing due to exposure was not confirmed.
Also, NRP BCG exposed to GSNO showed to have no deviation in results when compared to
unexposed NRP BCG.
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Figure Legends
Figure 1a. Growth Curve of Mid-log BCG Exposed to GSH. The mid-log BCG GSH growth
curve shows upon exposure to 8 mM GSH over five days, the OD600 does not exceed 0.25.
Unexposed mycobacteria reach a maximum OD600 of 0.80 over five days. No significant
deviations are noted for mycobacteria exposed to 4 mM GSH in comparison to unexposed
mycobacteria.
Figure 1b. Growth Curve of NRP BCG Exposed to GSH. Unexposed NRP BCG reached a
maximum OD600 of 0.15 over five days. NRP BCG exposed to 4 mM GSH reached a maximum
OD600 of 0.15, mimicking that of unexposed mycobacteria. Exposure to 8 mM GSH, NRP BCG
increased in OD600 from 0.10 (Day 1) to 0.40 (Day 5).
Figure 2a. Total Bacterial Cell Count of Mid-log BCG Exposed to GSH. This cell viability
assay reports quantifiable CFU through day three for unexposed, 4 and 8 mM GSH exposed
mycobacteria. On Day four and five, no viable CFU were quantitated upon exposure to 8 mM
GSH. The lateral axis is scaled to a maximum of 7.0 x 109. This represents the number of viable
cells in the overall culture tube; not normalized to OD600 of 0.1.
Figure 2b. Total Bacterial Cell Count of NRP BCG Exposed to GSH. This data represents
the CFU quantification for unexposed, 4 mM and 8 mM GSH NRP BCG over five days. The
data here is scaled to a maximum of viable cells present in the culture tube over five days. Note
the lateral axis of the graph to be 6.0 x 108 (This is 10 fold smaller than that of Figure 2a).
Primary region of focus is Day 5, where are substantially more viable bacteria present.
Figure 2c. Normalization of NRP BCG Exposed to GSH on Day 5 to OD600 = 0.1.
Normalization of Day 5 data from Figure 2b is shown, to determine the number of viable CFU at
an OD600 of 0.1. This data is shown for comparison reasons to determine the number of viable
bacterial cells present in the 8 mM GSH NRP BCG on Day 5 as shown in Figure 2b. Note that
the later axis of this graph extends to 6.0 x 108.
Figure 3a. Total Concentration of Free Intracellular ATP In Mid-log BCG Exposed to
GSH. The results shown here represent the free intracellular cytoplasmic concentration of ATP
in mid-log BCG over five days. Unexposed BCG had a maximum concentration of 1.38 µM over
five days. BCG exposed to 8 mM GSH resulted in a maximum ATP concentration of 2.28 µM on
Day four. On Day five, the intracellular ATP concentration of 8 mM exposed BCG decreased to
0.78 µM. 4 mM exposed BCG reached a maximum intracellular ATP concentration of 0.88 µM
on Day two. All data present represents cell cultures normalized to OD600 0.1.
Figure 3b. Total Concentration of Free Intracellular ATP In NRP BCG Exposed to GSH.
Intracellular cytoplasmic ATP concentration for unexposed NRP BCG increased to a maximum
of 1.70 µM on Day three. NRP BCG exposed to 4 mM GSH showed to have increased
concentrations of intracellular ATP; 0.4 µM between Days three to five. NRP BCG exposed to 8
mM GSH did not reveal a significant increase in intracellular ATP over the five-day period. All
data present represents cell cultures normalized to OD600 0.1.

Figure 4a. HPLC Mycothiol Analysis of NRP BCG Control on Day 1. This chromatogram
shows the thiol separation of Day 1 bacterial cells for unexposed bacteria, normalized to an
OD600 of 0.1. This sample was separated using 0.25% Acetic Acid (pH of 4.2). The average
retention times for the two regions are 12:36 minutes, and 18:52 minutes. Regions after 30
minutes are ghost peaks consistent with the media and other possible compounds. Regions of
interest include Region 2 (Cys-Gly/L-Cys) and Region 3 (Mycothiol). The average retention
time for Region 2 is 12.36 minutes; and for Region 3 it is the average retention time is 18:52
minutes.
Figure 4b. HPLC Mycothiol Analysis of NRP BCG Control on Day 5. The present
chromatogram represents thiol separation of unexposed NRP BCG on Day 5, normalized to an
OD600 of 0.1. This sample was analyzed using 0.25% Acetic Acid (pH of 4.2). The regions on
interest include Region 2 (Cys-Gly/L-Cys) and Region 3 (Mycothiol). The average retention
times for the two regions are 12:36 minutes, and 18:52 minutes. Regions after 30 minutes are
ghost peaks consistent with the media and other possible compounds.
HPLC Analysis of Cys-Gly, GSH, and MSH in NRP BCG Exposed to GSH on Day 5. NRP
BCG exposed to 8 mM GSH are separated using the HPLC thiol analysis method above. This
chromatogram represents the separation of exposed NRP BCG using 0.25% Acetic Acid (pH
4.2). The sample was normalized to OD600 of 0.1. The average retention times for the two
regions are 12:36 minutes, and 18:52 minutes. Regions after 30 minutes are ghost peaks
consistent with the media and other possible compounds. Regions of interest include 2 (CysGly/L-Cys), 2a (GSH/Cys-Gly/L-Cys), and 3 (Mycothiol). The average retention times for the
three regions are 12:36 minutes, 14:55 minutes, and 18:52 minutes.
Figure 4d. Changes In the Amount of MSH Present In NRP BCG Exposed to GSH Over 5
Days. This graph plots the average areas of Region 3 (Mycothiol) over five days to assess the
increase or decrease in cellular concentrations. The red line represents mycothiol concentrations
in 8 mM GSH exposed cells, while the blue represent the average mycothiol concentration
change over five days.
Figure 5a. Growth Curve of Mid-log BCG exposed to GSSG. The mid-log BCG GSSH
growth curve shows upon exposure to 8 mM GSH over five days, the OD600 does not exceed
0.24. Unexposed mycobacteria reach a maximum OD600 of 0.77 over five days. No significant
deviations are noted for mycobacteria exposed to 4 mM GSH in comparison to unexposed
mycobacteria. OD600 for 4 mM GSSG exposed does not exceed 0.31.
Figure 5b. Growth Curve of NRP BCG exposed to GSSG. Unexposed NRP BCG reached a
maximum OD600 value of 0.23, over five days. NRP BCG exposed to 4 mM GSSG increased to a
maximum OD600 of 0.24 over five days. 8 mM GSSG NRP BCG showed a maximum increase in
OD600 to 0.28 over the five-day period. These data show that there is no significant deviation
between unexposed, 4, and 8 mM GSSG exposed NRP BCG.
Figure 6a. Total Bacterial Cell Count of Mid-log BCG Exposed to GSSG. This cell viability
assay reports quantifiable CFU for unexposed, 4 and 8 mM GSSG exposed mid-log
mycobacteria over five days. There is no significant deviation for the number of CFU present for

unexposed, 4, and 8 mM GSSG samples. All data present represent cell cultures normalized to an
OD600 of 0.1.
Figure 6b. Total Bacterial Cell Count of NRP BCG Exposed to GSSG. This NRP BCG cell
viability figure shows the quantization of CFU for unexposed, 4, and 8 mM GSSG. Over the
five-day period, there is no significant difference in the number of CFU between all three trial
conditions. All data present represent cell cultures normalized to an OD600 of 0.1.
Figure 7a. Total Concentration of Free Intracellular ATP In Mid-log BCG Exposed to
GSH. The results shown here represent the free intracellular cytoplasmic concentration of ATP
in mid-log BCG over five days. Unexposed BCG had a maximum concentration of 1.31 µM
(Day 4) over five days. BCG exposed to 8 mM GSH resulted in a maximum ATP concentration
of 2.10 µM on Day 4. 4 mM exposed BCG reached a maximum intracellular ATP concentration
of 1.72 µM on Day 4. No statistical variation is noted in the data shown for unexposed, 4, and 8
mM GSSH exposed bacteria. All data present represents cell cultures normalized to OD600 0.1.
Figure 7b. Total Concentration of Free Intracellular ATP In NRP BCG Exposed to GSH.
The results shown here represent the free intracellular cytoplasmic concentration of ATP in NRP
BCG over five days. Unexposed BCG had a maximum concentration of 0.70 µM (Day 4) over
five days. BCG exposed to 8 mM GSH resulted in a maximum ATP concentration of 1.08 µM on
Day 4. 4 mM exposed BCG reached a maximum intracellular ATP concentration of 0.89 µM on
Day 4. No statistical variation is noted in the data shown for unexposed, 4, and 8 mM GSSH
exposed bacteria. All data present represents cell cultures normalized to OD600 0.1.
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Figure 1a. Growth Curve of Mid-log BCG Exposed to GSH.
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Figure 2a. Total Bacterial Cell Count of Mid-log BCG Exposed to GSH.
6.0E+08
5.0E+08

CFU

4.0E+08

0 mM GSH

3.0E+08

4 mM GSH

2.0E+08

8 mM GSH

1.0E+08
0.0E+00

Day 1

Day 2

Day 3

Day 4

Day 5

Figure 2b. Total Bacterial Cell Count of NRP BCG Exposed to GSH.
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Figure 2c. Normalization of NRP BCG Exposed to GSH on Day 5 to OD600 = 0.1.
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Figure 3a. Total Concentration of Free Intracellular ATP In Mid-log BCG Exposed to
GSH.
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Figure 3b. Total Concentration of Free Intracellular ATP In NRP BCG Exposed to GSH.

Figure 4a. HPLC Mycothiol Analysis of NRP BCG Control on Day 1.

Figure 4b. HPLC Mycothiol Analysis of NRP BCG Control on Day 5.

Figure 4c. HPLC Analysis of Cys-Gly, GSH, and MSH in NRP BCG Exposed to GSH on
Day 5.
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Figure 4d. Changes In the Amount of MSH Present In NRP BCG Exposed to GSH Over 5
Days.
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Figure 5a. Growth Curve of Mid-log BCG exposed to GSSG.
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Figure 6a. Total Bacterial Cell Count of Mid-log BCG Exposed to GSSG.
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Figure 6b. Total Bacterial Cell Count of NRP BCG Exposed to GSSG.
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Figure 7a. Total Concentration of Free Intracellular ATP In Mid-log BCG Exposed to
GSH.
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Figure 7b. Total Concentration of Free Intracellular ATP In NRP BCG Exposed to GSH.

